Pressure on the UK Government to accelerate long‑promised regulation of non‑surgical cosmetic procedures has intensified this week, following a strongly worded intervention from the Chartered Institute of Environmental Health (CIEH). In a letter to the House of Commons Science, Innovation and Technology Committee, CIEH urged MPs to call for faster implementation of the mandatory licensing scheme for non‑surgical cosmetic treatments—warning that continued delays are leaving the public exposed to avoidable harm.
CIEH’s letter highlights that nearly three years have passed since the Government consulted on the scope of the new licensing regime, yet no timetable has been set for the next stage of consultation on training, qualifications and enforcement. The organisation welcomed plans for the Care Quality Commission to regulate the highest‑risk procedures, but stressed that the wider licensing scheme—covering treatments such as dermal fillers, Botox and thread lifts—must be progressed without further narrowing of scope. Chair Judith Hedgley said the ongoing delay “puts members of the public at unnecessary risk of harm,” noting that the current framework remains inadequate and inconsistent.
The CIEH intervention adds to a growing chorus of organisations calling for urgent Government action. The Institute of Licensing (IoL), which has campaigned for statutory regulation has repeatedly warned that the absence of national licensing has enabled unsafe and unqualified practitioners to operate unchecked. The IoL welcomed the Government’s commitment to introduce statutory controls, describing it as a “landmark moment for public safety,” but emphasised that progress must now accelerate to deliver a robust, fit‑for‑purpose licensing regime.
Further pressure comes from Parliament. The All‑Party Parliamentary Group (APPG) on Beauty, Aesthetics and Wellbeing recently published its final report, concluding that the UK’s regulatory landscape has “not kept pace with rapid industry growth” and that Government inaction has left consumers at risk. The APPG called for a mandatory national licensing scheme covering practitioners and premises, national minimum training standards, statutory guidance for local authorities, and reclassification of dermal fillers as Prescription Only Medicines. Its recommendations align closely with the direction set by Section 180 of the Health and Care Act 2022, which gives ministers the power to introduce mandatory licensing in England.
The urgency of reform is underscored by developments in Scotland, where new regulations for non‑surgical cosmetic procedures have already come into force. The Non‑surgical Procedures and Functions of Medical Reviewers (Scotland) Act 2026 has begun its phased implementation, introducing criminal offences for providing treatments to under‑18s or operating without a licence, and granting inspectors powers of entry, search and seizure. Scotland’s move marks the first statutory licensing framework of its kind in the UK and demonstrates that meaningful regulatory action is both possible and overdue.
